Therapeutic Impact of Conversational Agent Interventions on Mental Health

Conversational Agent Interventions demonstrate measurable benefits for mental health, according to a meta-analysis of 48 randomized controlled trials involving 28,071 participants that found both AI-based and rule-based agents produced small-to-moderate reductions in depression (SMD −0.27), anxiety (SMD −0.20), and stress (SMD −0.26) on instruments such as the PHQ-9, GAD-7, and PSS.

Therapeutic Impact Confirmed

Effects held steady under robust variance estimation and multilevel modeling. The consistency of results across delivery platforms and agent architectures supports the reliability of conversational agents as scalable adjuncts within mental health service pathways. These Conversational Agent Interventions remained effective regardless of whether they were delivered through mobile or web platforms.

Low Variability Strengthens Findings

Subgroup analyses showed no significant differences by agent type, therapeutic approach, or outcome timing, although effects appeared slightly larger in non-clinical populations and shorter programs. Low heterogeneity (I² 2.8–31.4 %) and symmetrical funnel plots for depression and stress outcomes reinforced the stability of the pooled estimates. Risk-of-bias assessments indicated most trials carried low overall bias.

Rigorous Review Process

The review adhered to PRISMA 2020 guidelines and applied the GRADE framework, resulting in moderate certainty for depression and stress outcomes and low certainty for anxiety. Searches across PubMed, Scopus, and Web of Science identified 48 eligible RCTs published between 2015 and 2025, mainly from high-income countries and featuring cognitive behavioral therapy components. Rule-based systems dominated, while generative AI models appeared in only a small subset.

Pathway to Broader Access

Conversational Agent Interventions can help overcome workforce shortages, geographic barriers, and high treatment costs by providing on-demand, low-intensity support. Their scalability and anonymity make them well suited to resource-limited settings and periods of restricted in-person care, although further cost-effectiveness studies and long-term engagement data are needed before routine inclusion in reimbursement frameworks.